Eagle Genomics Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 125

Employees

  • Latest Deal Type
  • M&A

Eagle Genomics General Information

Description

Developer of a knowledge discovery platform designed to conduct data-intensive research in life sciences. The company's platform provides an easy-to-use intuitive approach for curating, integrating, sharing, analyzing, and valuing scientific data for clinical and molecular studies in life sciences and fields where similar challenges have been addressed, enabling scientist to deliver products and technologies into their respective markets.

Contact Information

Website
www.eaglegenomics.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 36-40 York Way
  • London N1 9AB
  • England, United Kingdom
+44 01223
Primary Industry
Other Healthcare Technology Systems
Other Industries
Biotechnology
Vertical(s)
Big Data, SaaS, Artificial Intelligence & Machine Learning, TMT, HealthTech
Corporate Office
  • 36-40 York Way
  • London N1 9AB
  • England, United Kingdom
+44 01223

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Eagle Genomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
16. Merger/Acquisition 10-Jan-2025 Completed Generating Revenue
15. Later Stage VC (Series D) 01-Sep-2023 Completed Generating Revenue
14. Secondary Transaction - Private 17-Oct-2022 Completed Generating Revenue
13. Accelerator/Incubator 01-Jan-2021 Completed Generating Revenue
12. Later Stage VC (Series A) 26-Oct-2020 Completed Generating Revenue
11. Accelerator/Incubator 12-Nov-2019 Completed Generating Revenue
10. Accelerator/Incubator 30-Jul-2019 Completed Generating Revenue
9. Later Stage VC (Series A) 04-Feb-2019 Completed Generating Revenue
8. Later Stage VC 20-Jun-2018 $1.13M $4.64M Completed Generating Revenue
7. Accelerator/Incubator 09-Mar-2018 $3.51M Completed Generating Revenue
To view Eagle Genomics’s complete valuation and funding history, request access »

Eagle Genomics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary 31,048 $0.012697 $107.13 $107.13 1x $107.13 7.97%
Ordinary 9,441 $0.012697 $112.33 $112.33 1x $112.33 2.42%
To view Eagle Genomics’s complete cap table history, request access »

Eagle Genomics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a knowledge discovery platform designed to conduct data-intensive research in life sciences. The company's
Other Healthcare Technology Systems
London, United Kingdom
125 As of 2023

Mountain View, CA
 

Brisbane, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Eagle Genomics Competitors (39)

One of Eagle Genomics’s 39 competitors is DNAnexus, a Venture Capital-Backed company based in Mountain View, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
DNAnexus Venture Capital-Backed Mountain View, CA
Second Genome Formerly VC-backed Brisbane, CA
PointCross Life Sciences Venture Capital-Backed Foster City, CA
Oxford Nanopore Technologies Formerly VC-backed Oxford, United Kingdom
Nebula Genomics Venture Capital-Backed Garden City, NY
You’re viewing 5 of 39 competitors. Get the full list »

Eagle Genomics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Eagle Genomics Former Investors (29)

Investor Name Investor Type Holding Investor Since Participating Rounds
ACF Investors Angel Group Minority
Aberdeen Asset Manager Minority
Angel (individual) Minority
Anatom Holding PE/Buyout Minority
Angels in Med City Angel Group Minority
You’re viewing 5 of 29 investors. Get the full list »

Ready to get started?

Request a free trial

Eagle Genomics FAQs

  • When was Eagle Genomics founded?

    Eagle Genomics was founded in 2008.

  • Where is Eagle Genomics headquartered?

    Eagle Genomics is headquartered in London, United Kingdom.

  • What is the size of Eagle Genomics?

    Eagle Genomics has 125 total employees.

  • What industry is Eagle Genomics in?

    Eagle Genomics’s primary industry is Other Healthcare Technology Systems.

  • Is Eagle Genomics a private or public company?

    Eagle Genomics is a Private company.

  • What is Eagle Genomics’s current revenue?

    The current revenue for Eagle Genomics is .

  • How much funding has Eagle Genomics raised over time?

    Eagle Genomics has raised $42.6M.

  • Who are Eagle Genomics’s investors?

    ACF Investors, Aberdeen, , Anatom Holding, and Angels in Med City are 5 of 29 investors who have invested in Eagle Genomics.

  • Who are Eagle Genomics’s competitors?

    DNAnexus, Second Genome, PointCross Life Sciences, Oxford Nanopore Technologies, and Nebula Genomics are some of the 39 competitors of Eagle Genomics.

  • When was Eagle Genomics acquired?

    Eagle Genomics was acquired on 10-Jan-2025.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »